Pricing Defining more than just a number.

In rare diseases and oncology, pricing must strike a delicate balance of rewarding value, enabling access, and supporting innovation, all under intense scrutiny.

Pricing requires methodological rigour, creativity and strategic clarity. We recognise the need to go beyond research and consider different perspectives and analytical approaches.

How we can support

At Dolon, we help our clients navigate complexity with confidence to craft a robust and communicable price strategy – credible from the boardroom to the negotiating table.

  • Pricing research

  • Pricing strategy and global pricing policies

  • Contracting strategy

  • Indication/market sequence optimisation

  • Life-cycle price evolution forecasting

  • Price defence narratives

  • Due diligence

The numbers

Proven
track record

250+

Projects
delivered

End-to-end
experience

70+

Negotiations
supported

Deep research
expertise

2000+

Pricing interviews
conducted

Explore more services

Learn More

Want to discuss your pricing needs with our experts?